[HTML][HTML] 分子靶向治疗在EGFR 突变肺鳞癌中的研究进展
B XIONG, KE Wenfei, W JIANG - Chinese Journal of Lung Cancer, 2024 - ncbi.nlm.nih.gov
非小细胞肺癌（ non-small cell lung cancer, NSCLC） 是我国常见的肿瘤之一，
肺鳞癌是NSCLC 中除肺腺癌外最常见的组织学亚型。 表皮生长因子受体（ epidermal growth …
肺鳞癌是NSCLC 中除肺腺癌外最常见的组织学亚型。 表皮生长因子受体（ epidermal growth …
Advances of Molecular Targeted Therapy in EGFR-mutated Squamous Cell Lung Cancer.
B Xiong, KE Wenfei, W Jiang - Chinese Journal of Lung …, 2024 - search.ebscohost.com
Non-small cell lung cancer (NSCLC) is a prevalent tumour type in our country, with lung
squamous carcinoma being a commonly observed NSCLC subtype besides lung …
squamous carcinoma being a commonly observed NSCLC subtype besides lung …
[PDF][PDF] Clinically Actionable Biomarker Identification in Solid Tumour Diagnostic Cellular Pathology
A Finall - 2024 - researchgate.net
In Caucasian populations the occurrence of EGFR mutations in lung adenocarcinoma is in
the region of 15% and tends to be more frequently, but not exclusively, seen in female …
the region of 15% and tends to be more frequently, but not exclusively, seen in female …